0000899751False00008997512026-11-132026-11-13
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 13, 2026
TITAN INTERNATIONAL, INC.
(Exact name of Registrant as specified in its Charter)
| | | | | | | | |
| Delaware | 1-12936 | 36-3228472 |
| (State of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
1525 Kautz Road, Suite 600, West Chicago, IL 60185
(Address of principal executive offices) (Zip Code)
(630) 377-0486
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | |
| Title of each class | Trading Symbol | Name of each exchange on which registered |
| Common stock, $0.0001 par value | TWI | New York Stock Exchange |
Item 8.01 Other Events.
As previously disclosed, on September 21, 2026, Titan International, Inc. (the “Company”) entered into a Sale and Purchase Agreement (the “Purchase Agreement”) pursuant to which the Company agreed to sell its ITM business. Beginning with the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, the historical results of the ITM business are presented as discontinued operations.
To assist investors in evaluating the Company’s continuing operations, the Company is providing supplemental historical financial information for the three months ended March 31, 2026 and 2025, and the three months ended June 30, 2026 and 2025, retrospectively revised to reflect the ITM business as discontinued operations. This supplemental financial information is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| | | | | |
| 99.1 | Unaudited supplemental historical financial information for the three months ended March 31, 2026 and 2025, and the three months ended June 30, 2026 and 2025, retrospectively revised to reflect the ITM business as discontinued operations. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| TITAN INTERNATIONAL, INC. |
| (Registrant) |
| | | | | | | | | | | |
| Date: | November 13, 2026 | By: | /s/ TONY C. EHELI |
| | | Tony C. Eheli |
| | | SVP and Chief Financial Officer |
| | | (Principal Financial Officer) |
TITAN INTERNATIONAL, INC.
Unaudited Condensed Consolidated Statements of Operations
Recast for Discontinued Operations
(All amounts in thousands, except per share data)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended |
| June 30, 2026 | | March 31, 2026 | | June 30, 2025 | | March 31, 2025 |
| | | | | | | |
Net sales | $ | 366,290 | | | $ | 395,153 | | | $ | 344,557 | | | $ | 384,956 | |
Cost of sales | 309,522 | | | 337,078 | | | 292,034 | | | 329,458 | |
| | | | | | | |
Gross profit | 56,768 | | | 58,075 | | | 52,523 | | | 55,498 | |
Selling, general, and administrative expenses | 44,558 | | | 44,235 | | | 44,968 | | | 42,984 | |
| | | | | | | |
Research and development expenses | 3,711 | | | 3,159 | | | 2,805 | | | 2,830 | |
Royalty expense | 2,653 | | | 2,410 | | | 2,419 | | | 2,446 | |
Restructuring and other charges | 834 | | | 25,142 | | | — | | | — | |
Income (loss) from operations | 5,012 | | | (16,871) | | | 2,331 | | | 7,238 | |
Interest expense | (10,054) | | | (9,887) | | | (9,674) | | | (9,534) | |
Interest income | 2,317 | | | 1,898 | | | 2,094 | | | 1,950 | |
| | | | | | | |
Foreign exchange loss | (75) | | | (321) | | | (1,969) | | | (819) | |
Other income | 506 | | | 756 | | | 993 | | | 697 | |
Loss from continuing operations before income taxes | (2,294) | | | (24,425) | | | (6,225) | | | (468) | |
(Benefit) provision for income taxes | (1,032) | | | 3,304 | | | 621 | | | 3,368 | |
Net loss from continuing operations | (1,262) | | | (27,729) | | | (6,846) | | | (3,836) | |
Net income from discontinued operations, net of tax | 7,602 | | | 3,479 | | | 3,242 | | | 3,858 | |
Net income (loss) | 6,340 | | | (24,250) | | | (3,604) | | | 22 | |
Net income (loss) attributable to noncontrolling interests | 576 | | | (36) | | | 941 | | | 671 | |
Net income (loss) attributable to Titan and applicable to common shareholders | $ | 5,764 | | | $ | (24,214) | | | $ | (4,545) | | | $ | (649) | |
| | | | | | | |
(Loss) earnings per common share: | | | | | | | |
Basic net loss from continuing operations per share | $ | (0.02) | | | $ | (0.43) | | | $ | (0.11) | | | $ | (0.06) | |
Basic net income (loss) per share attributable to Titan and applicable common stockholders | $ | 0.09 | | | $ | (0.38) | | | $ | (0.07) | | | $ | (0.01) | |
| | | | | | | |
Diluted net loss from continuing operations per share | $ | (0.02) | | | $ | (0.43) | | | $ | (0.11) | | | $ | (0.06) | |
Diluted net income (loss) per share attributable to Titan and applicable common stockholders | $ | 0.09 | | | $ | (0.38) | | | $ | (0.07) | | | $ | (0.01) | |
| | | | | | | |
Average common shares and equivalents outstanding: | | | | | | | |
Basic | 64,384 | | | 64,072 | | | 63,722 | | | 63,283 | |
Diluted | 64,504 | | | 64,072 | | | 63,722 | | | 63,283 | |
| | | | | | | |
| | | | | | | |
TITAN INTERNATIONAL, INC.
Unaudited Condensed Consolidated Statements of Cash Flows
Recast for Discontinued Operations
(All amounts in thousands) | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended |
Cash flows from operating activities: | June 30, 2026 | | March 31, 2026 | | June 30, 2025 | | March 31, 2025 |
Net income (loss) | $ | 6,340 | | | $ | (24,250) | | | $ | (3,604) | | | $ | 22 | |
Net income from discontinued operations, net of tax | 7,602 | | | 3,479 | | | 3,242 | | | 3,858 | |
Net loss from continuing operations | (1,262) | | | (27,729) | | | (6,846) | | | (3,836) | |
Adjustments to reconcile net loss to net cash provided by operating activities of continuing operations: | | | | | | | |
Depreciation and amortization | 13,702 | | | 13,592 | | | 13,443 | | | 12,868 | |
Restructuring and other charges | 834 | | | 25,142 | | | — | | | — | |
Deferred income tax (benefit) provision | (4,838) | | | 1,155 | | | 3,379 | | | (1,201) | |
| | | | | | | |
(Gain) loss on fixed asset and investment sale | (20) | | | 64 | | | (2) | | | 40 | |
| | | | | | | |
Stock-based compensation | 1,221 | | | 565 | | | 1,405 | | | (925) | |
| | | | | | | |
Issuance of stock under 401(k) plan | 420 | | | 418 | | | 431 | | | 396 | |
| | | | | | | |
Foreign currency (gain) loss | (1,217) | | | 1,464 | | | 14,367 | | | 3,180 | |
(Increase) decrease in assets: | | | | | | | |
Accounts receivable | 24,481 | | | (84,724) | | | 35,047 | | | (78,735) | |
Inventories | 3,222 | | | 7,736 | | | (12,895) | | | (2,318) | |
Prepaid and other current assets | (1,826) | | | 955 | | | (2,759) | | | (359) | |
Other assets | (2,912) | | | (3,245) | | | (2,961) | | | (1,417) | |
Increase in liabilities: | | | | | | | |
Accounts payable | (6,162) | | | 17,671 | | | (19,760) | | | 39,282 | |
Other current liabilities | 1,986 | | | 5,903 | | | (9,067) | | | 106 | |
Other liabilities | 2,626 | | | 569 | | | 1,658 | | | 410 | |
Net cash provided by (used for) operating activities of continuing operations | 30,255 | | | (40,464) | | | 15,440 | | | (32,509) | |
Net cash provided by (used for) operating activities of discontinued operations | 8,894 | | | (6,062) | | | (1,127) | | | (6,082) | |
Net cash provided by (used for) operating activities | 39,149 | | | (46,526) | | | 14,313 | | | (38,591) | |
Cash flows from investing activities: | | | | | | | |
Capital expenditures | (8,628) | | | (10,397) | | | (8,697) | | | (13,503) | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Proceeds (loss) from sale of fixed assets | 843 | | | (25) | | | 29 | | | 182 | |
| | | | | | | |
Net cash used for investing activities of continuing operations | (7,785) | | | (10,422) | | | (8,668) | | | (13,321) | |
Net cash used for investing activities of discontinued operations | (4,081) | | | (2,712) | | | (1,350) | | | (1,507) | |
Net cash used for investing activities | (11,866) | | | (13,134) | | | (10,018) | | | (14,828) | |
Cash flows from financing activities: | | | | | | | |
Proceeds from borrowings | 17,362 | | | 57,698 | | | 28,327 | | | 26,604 | |
| | | | | | | |
Repayments of debt | (35,890) | | | (32,686) | | | (29,335) | | | (6,496) | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Other financing activities | (22) | | | (195) | | | (133) | | | 98 | |
Net cash (used for) provided by financing activities of continuing operations | (18,550) | | | 24,817 | | | (1,141) | | | 20,206 | |
Net cash (used for) provided by financing activities of discontinued operations | (889) | | | 1,377 | | | (567) | | | (1,592) | |
Net cash (used for) provided by financing activities | (19,439) | | | 26,194 | | | (1,708) | | | 18,614 | |
Effect of exchange rate changes on cash | 679 | | | 1,849 | | | 7,652 | | | 13,261 | |
Net increase (decrease) in cash and cash equivalents | 8,523 | | | (31,617) | | | 10,239 | | | (21,544) | |
Cash and cash equivalents, beginning of period | 171,262 | | | 202,879 | | | 174,430 | | | 195,974 | |
Cash and cash equivalents, end of period | $ | 179,785 | | | $ | 171,262 | | | $ | 184,669 | | | $ | 174,430 | |
| | | | | | | |
Supplemental information: | | | | | | | |
Interest paid | $ | 17,260 | | | $ | 3,396 | | | $ | 17,959 | | | $ | 3,209 | |
Income taxes paid, net of refunds received | 4,299 | | | 2,137 | | | 4,714 | | | 3,421 | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
The table below provides a reconciliation of net loss to EBITDA and adjusted EBITDA, which are non-GAAP financial measures, for the three months ended June 30, 2026, March 31, 2026, June 30, 2025 and March 31, 2025 (in thousands).
| | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended |
| June 30, 2026 | | March 31, 2026 | | June 30, 2025 | | March 31, 2025 |
| | | | | | | |
Net loss from continuing operations | $ | (1,262) | | | $ | (27,729) | | | $ | (6,846) | | | $ | (3,836) | |
Adjustments: | | | | | | | |
(Benefit) provision for income taxes | (1,032) | | | 3,304 | | | 621 | | | 3,368 | |
Interest expense, excluding financing fees amortization | 9,897 | | | 9,972 | | | 9,759 | | | 9,592 | |
Depreciation and amortization | 13,702 | | | 13,592 | | | 13,443 | | | 12,868 | |
EBITDA from continuing operations | $ | 21,305 | | | $ | (861) | | | $ | 16,977 | | | $ | 21,992 | |
Adjustments: | | | | | | | |
Foreign exchange loss | 75 | | | 321 | | | 1,969 | | | 819 | |
Restructuring and impairment expenses | 834 | | | 25,142 | | | — | | | — | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Adjusted EBITDA from continuing operations | $ | 22,214 | | | $ | 24,602 | | | $ | 18,946 | | | $ | 22,811 | |
Adjusted EBITDA from discontinued operations | 11,946 | | | 6,754 | | | 11,213 | | | 8,012 | |
Adjusted EBITDA attributable to Titan and applicable to common shareholders | $ | 34,160 | | | $ | 31,356 | | | $ | 30,159 | | | $ | 30,823 | |